Biocytogen · 1 month ago
Business Development Manager- Product & Services
Biocytogen is a fast-growing biotech company specializing in cutting-edge technologies in immuno-oncology and gene engineering. The Business Development Manager will be responsible for exploring business opportunities, managing negotiations, and supporting marketing efforts to enhance the company's presence in the marketplace.
BiotechnologyHealth CareMedical DeviceTherapeutics
Responsibilities
Master the science and business skills in the above-mentioned fields
Actively reach out to prospective customers, explore business opportunities, manage negotiations and secure contracts
Attend trade shows/relevant conferences
Support the Marketing Team in branding and building awareness in the marketplace
Qualification
Required
Ph.D. in the bioscience field
Strong interest to learn advances in biopharmaceutical science and business
Enjoy networking with top scientists from biotech and biopharma companies
Excellent written and oral communication skills
Willingness to travel (i.e., customer meetings, conferences/vendor shows)
Preferred
Proven track record of revenue generation is a plus
Benefits
Medical Insurance
Dental Insurance
Vision Insurance
Health Reimbursement Accounts
Life and AD&D Insurance
Short & Long Term Disability Insurance
401K with Company Match
Paid Time Off
Paid Sick Days & Holidays
Company
Biocytogen
Biocytogen is a biopharmaceutical company that provides integrated solutions for antibody drug development.
H1B Sponsorship
Biocytogen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (10)
2024 (11)
2023 (3)
2022 (4)
2021 (2)
2020 (4)
Funding
Current Stage
Public CompanyTotal Funding
$335.15MKey Investors
CMB International Capital Corporation
2022-09-01IPO
2022-08-19Post Ipo Equity· $49.8M
2021-06-22Series E
Recent News
2026-01-11
2025-12-10
Company data provided by crunchbase